M. Arbyn

Statistics and Probability · 2006–2022

A researcher in the Science corpus: 14 papers; trusts 6 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

• Statistics and Probability — 25 citations into it
• Economics and Econometrics — 6 citations into it

Whom M. Arbyn trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. J. Ferlay
2. Jack Cuzick
3. F. Bray
4. Lawrence D. Brown
5. Dan Jackson
6. A. Jemal
7. V. Nyaga

Who trusts M. Arbyn overall

1. V. Nyaga
2. Virginia A. Moyer
3. P. Taylor

Papers from M. Arbyn's perspective

Ordered by how strongly the researchers M. Arbyn trusts endorse each paper. Same corpus, a different order for every researcher.

1. The causal relation between human papillomavirus and cervical cancer. (Journal of Clinical Pathology)
2. Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. (Vaccine)
3. Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update (International Journal of Cancer)
4. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. (Vaccine)
5. Overview of the European and North American studies on HPV testing in primary cervical cancer screening (International Journal of Cancer)
6. Epidemiologic classification of human papillomavirus types associated with cervical cancer. (New England Journal of Medicine)
7. What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. (Statistics in Medicine)
8. Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women of 30 years and older (International Journal of Cancer)
9. Human Papillomavirus and Cervical Cancer (Clinical Microbiology Reviews)
10. THE USE OF CONFIDENCE OR FIDUCIAL LIMITS ILLUSTRATED IN THE CASE OF THE BINOMIAL

Their papers

• Metaprop: a Stata command to perform meta-analysis of binomial data (2014) — 1,959 citations
• Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative (2022) — 1,192 citations
• The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries (2020) — 629 citations
• Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis (2019) — 3,192 citations
• Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses (2018) — 749 citations
• HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis. (2014) — 666 citations
• Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. (2014) — 1,597 citations
• Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. (2012) — 885 citations
• Worldwide burden of cervical cancer in 2008. (2011) — 1,104 citations
• European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition—Summary Document (2010) — 712 citations
• Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women of 30 years and older (2009) — 684 citations
• Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis (2008) — 712 citations
• Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. (2008) — 673 citations
• Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. (2006) — 1,151 citations